Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat
Clinical trial NCT06628713 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT06628713
- Sponsor
- KalVista Pharmaceuticals, Ltd.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.